Fig. 1From: Predictors of dopamine agonist resistance in prolactinoma patientsComparison of tumour volume in the responsive and resistant patient subgroup (significantly higher in resistant prolactinomas, p = 0.015, Mood’s median test, 95% CI)Back to article page